TIDMNSCI
RNS Number : 1038B
NetScientific PLC
31 May 2023
For release: 07.00, 31 May 2023
NetScientific plc
("NetScientific" or "NSCI" or the "Company" or the "Group")
Board Changes: Appointment of New Non-Executive Chair
London, UK - 31 May 2023: NetScientific plc (AIM: NSCI), the
investment and commercialisation group with an international
portfolio of innovative life science, sustainability and industrial
technology companies, is pleased to announce the strengthening of
its Board with the appointment of Charles Spicer as its new
independent Non-Executive Chair. He will also chair the Nominations
Committee and serve as a member of the Audit Committee and the
Remuneration Committee.
Charles will join the Company as a Non-Executive Director with
immediate effect, and he will then assume the role of Non-Executive
Chair following the closing of the Company's 2023 Annual General
Meeting ("AGM"), which is anticipated to be on or around 29 June
2023. Interim Non-Executive Chair, Jonathan Robinson will continue
in his role until the AGM, to facilitate an orderly handover.
Following the AGM Jonathan will continue to serve on the Board as a
Non-Executive Director, Senior Independent Director and Chair of
both the Audit Committee and the Remuneration Committee.
Charles Alexander Evan Spicer (aged 58) is an experienced chair
and director specialising in the medtech and life sciences
industries. He advises both public and private companies. He
currently chairs Creo Medical Group plc, IXICO plc, and Korn Wall
Limited (KwickScreen). Furthermore, he serves as the Chair for the
UK Department of Health's Product Development Awards Selection
Panel B for Invention for Innovation (i4i). Charles previously held
directorships at Aircraft Medical (acquired by Medtronic Inc. in
2015) and Stanmore Implants (acquired by Stryker Inc. in 2016).
Charles was previously Chief Executive of MDY Healthcare plc, a
strategic healthcare investor and, prior to that, Head of
Healthcare Corporate Finance at both Numis Securities and Nomura
International. Charles has a PhD in History from London University
and an MA in History from Cambridge University.
Dr Ilian Iliev, Chief Executive Officer of the Company,
commented:
"We are delighted to welcome Charles to our Board and are very
much looking forward to working with him. He has extensive
experience as a chair, director, and adviser to AIM companies, and
importantly combines this with a deep knowledge of our core
investment sectors and financial services. These attributes will
prove highly valuable as we continue to execute on our growth
strategy.
"I would also like to acknowledge the contributions of Jonathan
Robinson, who served as interim Chair. We are extremely grateful to
him for his interim board leadership, supporting the final stages
of our turnaround project. His measured and practical approach
contributed greatly to its success and we look forward to our
continued work together."
Charles currently holds or has held in the past five years the
following directorships and partnerships:
Current directorships and partnerships Past directorships and partnerships
Creo Medical Group plc 11 Health & Technologies Ltd
IXICO plc MJ Hudson Group plc
Korn Wall Ltd Realm Therapeutics Ltd
Newe House Partners
Charles Spicer does not hold any interest in the share capital
of the Company.
No further disclosure is required under paragraph (g) of
Schedule Two of the AIM Rules for Companies.
-Ends-
The person responsible for arranging the release of this
announcement on behalf of the Company is Ilian Iliev, Chief
Executive Officer of the Company.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH
IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT
2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.
For more information, please contact:
NetScientific
Ilian Iliev, CEO Via Belvedere Communications
WH Ireland (Nominated adviser and broker)
Chris Fielding / Darshan Patel / Enzo Aliaj +44 (0)20 7220
1666
Belvedere Communications
John West / Llew Angus +44 (0) 203 008 6867
Email: nsci@belvederepr.com
About NetScientific
NetScientific plc (AIM: NSCI) is an investment and
commercialisation group with an international portfolio of
innovative life science, sustainability and technology
companies.
NetScientific identifies, invests in, and builds high growth
companies in the UK and internationally. The company adds value
through the proactive management of its portfolio, progressing to
key value inflection points, and delivering investment returns
through partial or full liquidity events.
NetScientific differentiates itself by employing a capital-light
investment approach, making judicial use of its balance sheet and
syndicating investments through its wholly owned VC subsidiary, EMV
Capital. The group secures a mixture of direct equity stakes and
carried interest stakes in its portfolio of companies, creating a
lean structure that can support a large portfolio.
NetScientific is headquartered in London, United Kingdom, and is
admitted to trading on AIM, a market operated by the London Stock
Exchange.
www.netscientific.net
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAABMMTMTJJMPJ
(END) Dow Jones Newswires
May 31, 2023 02:00 ET (06:00 GMT)
Netscientific (LSE:NSCI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Netscientific (LSE:NSCI)
Gráfica de Acción Histórica
De May 2023 a May 2024